Loveland B, Hunt R, Malkovský M
Immunology. 1986 Sep;59(1):159-61.
The intraperitoneal (i.p.) administration of autologous spleen cells treated with recombinant interleukin-2 (IL-2) in vitro resulted in the rejection of C57BL/10ScSn (B10) skin grafts that had survived for 18 months on CBA/Ca mice tolerant to B10 alloantigens. Cytotoxic lymphocytes specific for the graft alloantigens, assayed by limiting dilution analysis, appeared after the breaking of this immunological tolerance, whereas they were not detectable in tolerant mice. In these mice the frequencies of precursor cytotoxic cells specific for third-party alloantigens were unaffected by the IL-2 treatment.
在体外经重组白细胞介素-2(IL-2)处理的自体脾细胞腹腔内(i.p.)给药,导致在对B10同种异体抗原耐受的CBA/Ca小鼠身上存活了18个月的C57BL/10ScSn(B10)皮肤移植物被排斥。通过有限稀释分析检测,针对移植物同种异体抗原的细胞毒性淋巴细胞在这种免疫耐受被打破后出现,而在耐受小鼠中则检测不到。在这些小鼠中,针对第三方同种异体抗原的前体细胞毒性细胞频率不受IL-2处理的影响。